People with chronic obstructive pulmonary disease (COPD) need to continue to use maintenance medications as prescribed throughout the COVID-19 pandemic, and do all they can to avoid infection, the American Lung Association said in an update. This virus poses a considerably greater risk of serious complications to these patients and…
News
A single dose of a pressurized metered-dose inhaler formulation of ensifentrine (RPL544) significantly improved lung function, compared to a placebo, in people with moderate-to-severe chronic obstructive pulmonary disease (COPD), Verona Pharma announced. These results are from part A, the single-dose part, of a Phase 2 trial (NCT04091360) underway in two…
At 3 a.m. on July 6, 2003, Miami resident Jeffrey Goldstein got a call that would change his life. Doctors at the Duke University Lung Transplant Clinic had found a lung donor match for Goldstein, who had been diagnosed with pulmonary fibrosis two years earlier. Nearly 17 years…
People with chronic obstructive pulmonary disease (COPD) are among the most vulnerable to COVID-19 infections, being even more likely to develop severe disease or to be admitted to intensive care units (ICU) than those with diseases like high blood pressure or diabetes, an analysis of several…
Low levels of the protein CC16 in blood are associated with worse lung function and more severe disease among people with chronic obstructive pulmonary disease (COPD), a new study suggests. The study, “Reduced Serum Concentration of CC16 Is Associated with Severity of Chronic Obstructive Pulmonary Disease…
People with chronic obstructive pulmonary disease (COPD) who also have gastroesophageal reflux disease (GERD) — commonly called acid reflux — have a higher risk of experiencing acute exacerbations, a systematic review suggested. That review study, “…
Use of chemical disinfectants might increase the risk of chronic obstructive pulmonary disease (COPD) in nurses, a study suggests. The study, “Association of Occupational Exposure to Disinfectants With Incidence of Chronic Obstructive Pulmonary Disease Among US Female Nurses,” was published in the journal JAMA Network…
In recognition of Rare Disease Day Feb. 29, Bionews Services launched a social media campaign last month asking patients to describe what makes them rare. Running Feb. 7–29, the #WhatMakesMeRare campaign was aimed at uplifting people with rare diseases by encouraging them to share their stories and perspectives. The…
You literally can’t miss it in the news these days — millions (if not billions) of people all over the world are talking about the increasing spread of “the new (novel) Coronavirus.” According to the Center for Disease Control (CDC), the earliest cases of COVID-19 began in the city of…
Signant Health and Propeller Health are connecting their systems to help improve asthma and chronic obstructive pulmonary disease (COPD) patients’ adherence to inhaled medication and symptom control. Signant said it will connect its TrialMax electronic clinical outcome assessment (eCOA) platform to Propeller’s digital health platform for…
Recent Posts
- The value of tapping into COPD community resources
- Tozorakimab reduces COPD exacerbations in two large clinical trials
- Losing myself, finding myself: How recovery is harder with COPD
- Redrawing the geography of my life one breath at a time
- A diagnosis is a map that shows our way through an unknown land